Mavoglurant racemate
≥98%
- Product Code: 58713
CAS:
1636881-61-2
| Molecular Weight: | 313.39 g./mol | Molecular Formula: | C₁₉H₂₃NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Mavoglurant racemate is primarily investigated for its potential in treating neurological and psychiatric disorders. It acts as a selective antagonist of the metabotropic glutamate receptor 5 (mGluR5), which is implicated in various brain functions and dysfunctions. Research has focused on its application in conditions such as fragile X syndrome, a genetic disorder causing intellectual disability and behavioral challenges. By modulating glutamate signaling, it aims to improve cognitive and behavioral symptoms. Additionally, studies have explored its use in addiction treatment, particularly for reducing cravings in substance abuse disorders. Its role in anxiety and depression has also been examined, though clinical efficacy remains under investigation. Overall, it represents a promising therapeutic candidate for disorders linked to glutamate dysregulation.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿35,910.00 |
+
-
|
| 0.005 | 10-20 days | ฿71,820.00 |
+
-
|
Mavoglurant racemate
Mavoglurant racemate is primarily investigated for its potential in treating neurological and psychiatric disorders. It acts as a selective antagonist of the metabotropic glutamate receptor 5 (mGluR5), which is implicated in various brain functions and dysfunctions. Research has focused on its application in conditions such as fragile X syndrome, a genetic disorder causing intellectual disability and behavioral challenges. By modulating glutamate signaling, it aims to improve cognitive and behavioral symptoms. Additionally, studies have explored its use in addiction treatment, particularly for reducing cravings in substance abuse disorders. Its role in anxiety and depression has also been examined, though clinical efficacy remains under investigation. Overall, it represents a promising therapeutic candidate for disorders linked to glutamate dysregulation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :